Australia’s Covid vaccine review recommends expansion of Novavax eligibility amid fears of Moderna shortfall

Australia’s vaccination advisory body is investigating whether to expand the availability of the Novavax Covid jab, amid concerns tens of millions of doses could be wasted due to recommendations it not be used as a general booster shot. It comes as a review of Australia’s Covid vaccine procurement found the former Coalition government’s actions were “consistent with other high-income countries”, but warned of a potential shortfall in Moderna unless the Labor government orders more supply. The review, by respected public servant Prof Jane Halton, said Australia had not reached what she called “Covid-stable”, where regular ebbs and flows of the virus could be predicted